GLIPR1L1
GLIPR1-like protein 1
Also known as: GPRL1_HUMAN, MGC26856
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UWM5
- Gene
- GLIPR1L1
- Ensembl
- ENSG00000173401
- Chromosome
- 12
- Canonical length
- 242 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
Predicted to enable molecular adaptor activity. Predicted to be involved in fusion of sperm to egg plasma membrane involved in single fertilization and protein localization involved in acrosome reaction. Predicted to act upstream of or within binding activity of sperm to zona pellucida. Predicted to be located in acrosomal vesicle and sperm head-tail coupling apparatus. Predicted to be part of protein complex involved in cell-cell adhesion. Predicted to be active in extracellular space and outer acrosomal membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
242 residues, UniProt reviewed canonical sequence.
>Q6UWM5|GLIPR1L1
1 MALKNKFSCL WILGLCLVAT TSSKIPSITD PHFIDNCIEA HNEWRGKVNP PAADMKYMIW
61 DKGLAKMAKA WANQCKFEHN DCLDKSYKCY AAFEYVGENI WLGGIKSFTP RHAITAWYNE
121 TQFYDFDSLS CSRVCGHYTQ LVWANSFYVG CAVAMCPNLG GASTAIFVCN YGPAGNFANM
181 PPYVRGESCS LCSKEEKCVK NLCRTPQLII PNQNPFLKPT GRAPQQTAFN PFSLGFLLLR
241 IFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLIPR1L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- testis: 29 nTPM
- skin: 0.5 nTPM
- adrenal gland: 0.4 nTPM
- cerebellum: 0.3 nTPM
- endometrium: 0.3 nTPM
- heart muscle: 0.3 nTPM
Single-cell type
- late primary spermatocytes: 503 nCPM
- cardiomyocytes: 316 nCPM
- early spermatids: 221 nCPM
- adipocytes: 113 nCPM
- fibro-adipogenic progenitors: 82 nCPM
- epicardial cells: 68 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 5.6 nTPM
- basal ganglia: 4.6 nTPM
- white matter: 4.6 nTPM
- midbrain: 4.4 nTPM
- hypothalamus: 4.2 nTPM
- medulla oblongata: 4.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLIPR1L1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLIPR1L1 as an antibody target. Whether an autoantibody or antibody against GLIPR1L1 could matter depends on whether native GLIPR1L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLIPR1L1 is annotated at the cell surface, where native GLIPR1L1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GLIPR1L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...